Atlas Trials

A Study on Estimated Risks of Certain Adverse Events in Adults With Von Willebrand Disease (VWD) Treated With Veyvondi

Clinical trial NCT05265078 · COMPLETED

Trial details

NCT number
NCT05265078
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Von Willebrand Disease (VWD)
Start date
2022-06-08
Primary completion
2023-04-06
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.